Cutaneous involvement by T-cell prolymphocytic leukemia presenting as livedoid vasculopathy. 2021

Bruce D Leckey, and Meenal K Kheterpal, and M Angelica Selim, and Rami N Al-Rohil
Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA.

T-cell prolymphocytic leukemia (T-PLL) is a rare, aggressive neoplasm derived from post-thymic T-cells. Patients are typically middle aged with a slight male predominance who present with a high white blood cell count, hepatosplenomegaly, lymphadenopathy, and other symptoms typically associated with leukemia. Although cutaneous involvement has been reported in up to 30% of cases of T-PLL, to our knowledge, none have presented with a presentation resembling livedoid vasculopathy. In the correct clinical context, an underlying hematolymphoid neoplasm should be included in the differential diagnosis of a patient presenting with livedoid vasculopathy.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005076 Exanthema Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology. Rash,Skin Rash,Exanthem,Rash, Skin
D005121 Extremities The farthest or outermost projections of the body, such as the HAND and FOOT. Limbs,Extremity,Limb
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069461 Bendamustine Hydrochloride A nitrogen mustard compound that functions as an ALKYLATING ANTINEOPLASTIC AGENT and is used in the treatment of CHRONIC LYMPHOCYTIC LEUKEMIA and NON-HODGKIN'S LYMPHOMA. Bendamustin,Bendamustine,Cytostasan,IMET 3393,Ribomustin,Treanda,Zimet 3393,Hydrochloride, Bendamustine
D000074322 Antineoplastic Agents, Immunological Antineoplastic agents containing immunological agents (e.g. MAbs). These pharmacologic preparations inhibit or prevent the proliferation of NEOPLASMS. Antineoplastic MAbs,Antineoplastics, Monoclonal Antibodies,Antineoplastics, Monoclonal Antibody,MAbs, Antineoplastic,Monoclonal Antibodies, Antineoplastic,Antibodies Antineoplastics, Monoclonal,Antineoplastic Monoclonal Antibodies,Immunological Antineoplastic Agents,Monoclonal Antibodies Antineoplastics,Monoclonal Antibody Antineoplastics
D000074323 Alemtuzumab An anti-CD52 ANTIGEN monoclonal antibody used for the treatment of certain types of CD52-positive lymphomas (e.g., CHRONIC LYMPHOCYTIC LEUKEMIA; CUTANEOUS T-CELL LYMPHOMA; and T-CELL LYMPHOMA). Its mode of actions include ANTIBODY-DEPENDENT CELL CYTOTOXICITY. Campath,Campath 1G,Campath 1H,Campath 1M,Campath-1-G,Campath-1G,Campath-1H,Campath-1M,Lemtrada,MabCambath,Monoclonal Antibody Campath-1H,Antibody Campath-1H, Monoclonal,Campath 1 G,Campath-1H, Monoclonal Antibody,Campath1G,Campath1H,Monoclonal Antibody Campath 1H
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Bruce D Leckey, and Meenal K Kheterpal, and M Angelica Selim, and Rami N Al-Rohil
March 2012, Indian journal of dermatology,
Bruce D Leckey, and Meenal K Kheterpal, and M Angelica Selim, and Rami N Al-Rohil
July 2019, Blood,
Bruce D Leckey, and Meenal K Kheterpal, and M Angelica Selim, and Rami N Al-Rohil
July 2018, Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion,
Bruce D Leckey, and Meenal K Kheterpal, and M Angelica Selim, and Rami N Al-Rohil
January 2011, Middle East African journal of ophthalmology,
Bruce D Leckey, and Meenal K Kheterpal, and M Angelica Selim, and Rami N Al-Rohil
August 2001, American journal of ophthalmology,
Bruce D Leckey, and Meenal K Kheterpal, and M Angelica Selim, and Rami N Al-Rohil
October 2021, International journal of laboratory hematology,
Bruce D Leckey, and Meenal K Kheterpal, and M Angelica Selim, and Rami N Al-Rohil
January 1989, Annales de dermatologie et de venereologie,
Bruce D Leckey, and Meenal K Kheterpal, and M Angelica Selim, and Rami N Al-Rohil
January 1995, Annales de dermatologie et de venereologie,
Bruce D Leckey, and Meenal K Kheterpal, and M Angelica Selim, and Rami N Al-Rohil
February 2013, Cutis,
Bruce D Leckey, and Meenal K Kheterpal, and M Angelica Selim, and Rami N Al-Rohil
November 2004, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology,
Copied contents to your clipboard!